KTB Ventures Joins $30M Series B Round In CARsgen

Login to View

Chinese pharmaceutical start-up CARsgen Therapeutics has completed a US$30 million series B round of financing led by KTB Ventures and Jolly Innovation Ventures, according to an announcement.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in